▶ 調査レポート

着床前遺伝子スクリーニング(PGS)技術の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Preimplantation Genetic Screening (PGS) Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。着床前遺伝子スクリーニング(PGS)技術の世界市場2020年:企業別、地域別、種類・用途別 / Global Preimplantation Genetic Screening (PGS) Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-02350資料のイメージです。• レポートコード:D0GIR-02350
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、着床前遺伝子スクリーニング(PGS)技術の世界市場を広く調査・分析し、今後の市場展望をまとめております。着床前遺伝子スクリーニング(PGS)技術の種類別市場規模(次世代シーケンシング、ポリメラーゼ連鎖反応、蛍光in Situハイブリダイゼーション、比較ゲノムハイブリダイゼーション、一塩基多型)、用途別市場規模(マタニティセンター&不妊治療クリニック、病院、研究所、学術機関、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Illumina、Oxford Gene Technology、PerkinElmer、Thermo Fisher Scientific、Takara Bio、Agilent Technologies、Genea、Natera、Coopersurgical、INVICTA、Progenesis、Igenomix、Reproductive Health and Wellness Center
・地域別グローバル市場分析 2015年-2020年
・着床前遺伝子スクリーニング(PGS)技術の北米市場(アメリカ、カナダ、メキシコ)
・着床前遺伝子スクリーニング(PGS)技術のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・着床前遺伝子スクリーニング(PGS)技術のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・着床前遺伝子スクリーニング(PGS)技術の南米市場(ブラジル、アルゼンチン)
・着床前遺伝子スクリーニング(PGS)技術の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:次世代シーケンシング、ポリメラーゼ連鎖反応、蛍光in Situハイブリダイゼーション、比較ゲノムハイブリダイゼーション、一塩基多型
・用途別分析:マタニティセンター&不妊治療クリニック、病院、研究所、学術機関、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Preimplantation Genetic Screening (PGS) Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Preimplantation Genetic Screening (PGS) Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Preimplantation Genetic Screening (PGS) Technology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Preimplantation Genetic Screening (PGS) Technology market has been segmented into:
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism

By Application, Preimplantation Genetic Screening (PGS) Technology has been segmented into:
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Preimplantation Genetic Screening (PGS) Technology market presented in the report. This section sheds light on the sales growth of different regional and country-level Preimplantation Genetic Screening (PGS) Technology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Preimplantation Genetic Screening (PGS) Technology market.

The report offers in-depth assessment of the growth and other aspects of the Preimplantation Genetic Screening (PGS) Technology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Preimplantation Genetic Screening (PGS) Technology Market Share Analysis
Preimplantation Genetic Screening (PGS) Technology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Preimplantation Genetic Screening (PGS) Technology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Preimplantation Genetic Screening (PGS) Technology sales, revenue and market share for each player covered in this report.

The major players covered in Preimplantation Genetic Screening (PGS) Technology are:
Illumina
Oxford Gene Technology
PerkinElmer
Thermo Fisher Scientific
Takara Bio
Agilent Technologies
Genea
Natera
Coopersurgical
INVICTA
Progenesis
Igenomix
Reproductive Health and Wellness Center
Among other players domestic and global, Preimplantation Genetic Screening (PGS) Technology market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Preimplantation Genetic Screening (PGS) Technology Market Overview
1.1 Product Overview and Scope of Preimplantation Genetic Screening (PGS) Technology
1.2 Classification of Preimplantation Genetic Screening (PGS) Technology by Type
1.2.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2019
1.2.3 Next-generation Sequencing
1.2.4 Polymerase Chain Reaction
1.2.5 Fluorescence in Situ Hybridization
1.2.6 Comparative Genomic Hybridization
1.2.7 Single-nucleotide Polymorphism
1.3 Global Preimplantation Genetic Screening (PGS) Technology Market by Application
1.3.1 Overview: Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals
1.3.4 Research Laboratories & Academic Institutes
1.3.5 Others
1.4 Global Preimplantation Genetic Screening (PGS) Technology Market by Regions
1.4.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Preimplantation Genetic Screening (PGS) Technology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Preimplantation Genetic Screening (PGS) Technology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Preimplantation Genetic Screening (PGS) Technology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Preimplantation Genetic Screening (PGS) Technology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Preimplantation Genetic Screening (PGS) Technology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Preimplantation Genetic Screening (PGS) Technology Status and Prospect (2015-2025)
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina SWOT Analysis
2.1.4 Illumina Product and Services
2.1.5 Illumina Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Oxford Gene Technology
2.2.1 Oxford Gene Technology Details
2.2.2 Oxford Gene Technology Major Business
2.2.3 Oxford Gene Technology SWOT Analysis
2.2.4 Oxford Gene Technology Product and Services
2.2.5 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.3 PerkinElmer
2.3.1 PerkinElmer Details
2.3.2 PerkinElmer Major Business
2.3.3 PerkinElmer SWOT Analysis
2.3.4 PerkinElmer Product and Services
2.3.5 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takara Bio
2.5.1 Takara Bio Details
2.5.2 Takara Bio Major Business
2.5.3 Takara Bio SWOT Analysis
2.5.4 Takara Bio Product and Services
2.5.5 Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business
2.6.3 Agilent Technologies Product and Services
2.6.4 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genea
2.7.1 Genea Details
2.7.2 Genea Major Business
2.7.3 Genea Product and Services
2.7.4 Genea Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Natera
2.8.1 Natera Details
2.8.2 Natera Major Business
2.8.3 Natera Product and Services
2.8.4 Natera Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Coopersurgical
2.9.1 Coopersurgical Details
2.9.2 Coopersurgical Major Business
2.9.3 Coopersurgical Product and Services
2.9.4 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.10 INVICTA
2.10.1 INVICTA Details
2.10.2 INVICTA Major Business
2.10.3 INVICTA Product and Services
2.10.4 INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.11 Progenesis
2.11.1 Progenesis Details
2.11.2 Progenesis Major Business
2.11.3 Progenesis Product and Services
2.11.4 Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.12 Igenomix
2.12.1 Igenomix Details
2.12.2 Igenomix Major Business
2.12.3 Igenomix Product and Services
2.12.4 Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
2.13 Reproductive Health and Wellness Center
2.13.1 Reproductive Health and Wellness Center Details
2.13.2 Reproductive Health and Wellness Center Major Business
2.13.3 Reproductive Health and Wellness Center Product and Services
2.13.4 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Preimplantation Genetic Screening (PGS) Technology Players Market Share
3.2.2 Top 10 Preimplantation Genetic Screening (PGS) Technology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Market Share by Regions
4.2 North America Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
4.3 Europe Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
4.5 South America Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
5 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Countries
5.1 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Countries (2015-2020)
5.2 USA Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
5.3 Canada Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
5.4 Mexico Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
6 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Countries
6.1 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Countries (2015-2020)
6.2 Germany Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
6.3 UK Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
6.4 France Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
6.5 Russia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
6.6 Italy Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Countries
7.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Countries (2015-2020)
7.2 China Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
7.3 Japan Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
7.4 Korea Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
7.5 India Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
8 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Countries
8.1 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Countries (2015-2020)
8.2 Brazil Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
8.3 Argentina Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Preimplantation Genetic Screening (PGS) Technology by Countries
9.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
9.3 UAE Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
9.4 Egypt Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
9.5 South Africa Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Market Share by Type (2015-2020)
10.2 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast by Type (2019-2024)
10.3 Next-generation Sequencing Revenue Growth Rate (2015-2025)
10.4 Polymerase Chain Reaction Revenue Growth Rate (2015-2025)
10.5 Fluorescence in Situ Hybridization Revenue Growth Rate (2015-2025)
10.6 Comparative Genomic Hybridization Revenue Growth Rate (2015-2025)
10.7 Single-nucleotide Polymorphism Revenue Growth Rate (2015-2025)
11 Global Preimplantation Genetic Screening (PGS) Technology Market Segment by Application
11.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2015-2020)
11.2 Preimplantation Genetic Screening (PGS) Technology Market Forecast by Application (2019-2024)
11.3 Maternity Centers & Fertility Clinics Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Research Laboratories & Academic Institutes Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Preimplantation Genetic Screening (PGS) Technology Market Size Forecast (2021-2025)
12.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size Forecast (2021-2025)
12.2 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast by Regions (2021-2025)
12.3 North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
12.4 Europe Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
12.6 South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Preimplantation Genetic Screening (PGS) Technology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Preimplantation Genetic Screening (PGS) Technology Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Illumina Corporate Information, Location and Competitors
Table 7. Illumina Preimplantation Genetic Screening (PGS) Technology Major Business
Table 8. Illumina Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 9. Illumina SWOT Analysis
Table 10. Illumina Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 11. Illumina Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Oxford Gene Technology Corporate Information, Location and Competitors
Table 13. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Major Business
Table 14. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2018-2019)
Table 15. Oxford Gene Technology SWOT Analysis
Table 16. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 17. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. PerkinElmer Corporate Information, Location and Competitors
Table 19. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Major Business
Table 20. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 21. PerkinElmer SWOT Analysis
Table 22. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 23. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 25. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Major Business
Table 26. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 27. Thermo Fisher Scientific SWOT Analysis
Table 28. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 29. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Takara Bio Corporate Information, Location and Competitors
Table 31. Takara Bio Preimplantation Genetic Screening (PGS) Technology Major Business
Table 32. Takara Bio Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 33. Takara Bio SWOT Analysis
Table 34. Takara Bio Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 35. Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Agilent Technologies Corporate Information, Location and Competitors
Table 37. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Major Business
Table 38. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 39. Agilent Technologies SWOT Analysis
Table 40. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 41. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Genea Corporate Information, Location and Competitors
Table 43. Genea Preimplantation Genetic Screening (PGS) Technology Major Business
Table 44. Genea Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 45. Genea SWOT Analysis
Table 46. Genea Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 47. Genea Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Natera Corporate Information, Location and Competitors
Table 49. Natera Preimplantation Genetic Screening (PGS) Technology Major Business
Table 50. Natera Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 51. Natera SWOT Analysis
Table 52. Natera Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 53. Natera Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Coopersurgical Corporate Information, Location and Competitors
Table 55. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Major Business
Table 56. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 57. Coopersurgical SWOT Analysis
Table 58. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 59. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. INVICTA Corporate Information, Location and Competitors
Table 61. INVICTA Preimplantation Genetic Screening (PGS) Technology Major Business
Table 62. INVICTA Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 63. INVICTA SWOT Analysis
Table 64. INVICTA Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 65. INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Progenesis Corporate Information, Location and Competitors
Table 67. Progenesis Preimplantation Genetic Screening (PGS) Technology Major Business
Table 68. Progenesis Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 69. Progenesis SWOT Analysis
Table 70. Progenesis Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 71. Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Igenomix Corporate Information, Location and Competitors
Table 73. Igenomix Preimplantation Genetic Screening (PGS) Technology Major Business
Table 74. Igenomix Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 75. Igenomix SWOT Analysis
Table 76. Igenomix Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 77. Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Reproductive Health and Wellness Center Corporate Information, Location and Competitors
Table 79. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Major Business
Table 80. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Total Revenue (USD Million) (2017-2018)
Table 81. Reproductive Health and Wellness Center SWOT Analysis
Table 82. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 83. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) by Players (2015-2020)
Table 85. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players (2015-2020)
Table 86. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) by Regions (2015-2020)
Table 87. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Regions (2015-2020)
Table 88. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Countries (2015-2020)
Table 89. North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Table 90. Europe Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) by Countries (2015-2020)
Table 91. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) by Countries (2015-2020)
Table 92. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Countries (2015-2020)
Table 93. South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Table 94. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) by Countries (2015-2020)
Table 95. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Table 96. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) by Type (2015-2020)
Table 97. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type (2015-2020)
Table 98. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Type (2021-2025)
Table 99. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2015-2020)
Table 100. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Application (2015-2020)
Table 101. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Application (2021-2025)
Table 102. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Preimplantation Genetic Screening (PGS) Technology Picture
Figure 2. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2019
Figure 3. Next-generation Sequencing Picture
Figure 4. Polymerase Chain Reaction Picture
Figure 5. Fluorescence in Situ Hybridization Picture
Figure 6. Comparative Genomic Hybridization Picture
Figure 7. Single-nucleotide Polymorphism Picture
Figure 8. Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application in 2019
Figure 9. Maternity Centers & Fertility Clinics Picture
Figure 10. Hospitals Picture
Figure 11. Research Laboratories & Academic Institutes Picture
Figure 12. Others Picture
Figure 13. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2019
Figure 22. Global Top 10 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Regions (2015-2020)
Figure 26. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Regions in 2018
Figure 27. North America Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 28. Europe Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 30. South America Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 32. North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Figure 33. North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries in 2019
Figure 34. USA Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 35. Canada Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 37. Europe Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries in 2019
Figure 39. Germany Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 40. UK Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 41. France Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 42. Russia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 43. Italy Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries in 2019
Figure 46. China Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 47. Japan Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 48. Korea Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 49. India Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 51. South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Figure 52. South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries in 2019
Figure 53. Brazil Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 58. UAE Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2015-2020)
Figure 61. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type (2015-2020)
Figure 62. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type in 2019
Figure 63. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Type (2021-2025)
Figure 64. Global Next-generation Sequencing Revenue Growth Rate (2015-2020)
Figure 65. Global Polymerase Chain Reaction Revenue Growth Rate (2015-2020)
Figure 66. Global Fluorescence in Situ Hybridization Revenue Growth Rate (2015-2020)
Figure 67. Global Comparative Genomic Hybridization Revenue Growth Rate (2015-2020)
Figure 68. Global Single-nucleotide Polymorphism Revenue Growth Rate (2015-2020)
Figure 69. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Application (2015-2020)
Figure 70. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Application in 2019
Figure 71. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Application (2021-2025)
Figure 72. Global Maternity Centers & Fertility Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 74. Global Research Laboratories & Academic Institutes Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
Figure 80. Europe Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
Figure 82. South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel